# Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia

> **NCT01384214** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 28 (actual)

## Conditions studied

- Torticollis

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A

## Key facts

- **NCT ID:** NCT01384214
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2011-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01384214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01384214, "Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01384214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*